terlipressin has been researched along with Acute Kidney Failure in 50 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (2.00) | 18.2507 |
| 2000's | 1 (2.00) | 29.6817 |
| 2010's | 25 (50.00) | 24.3611 |
| 2020's | 23 (46.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allegretti, AS; Belcher, JM; Chung, RT; Garcia-Tsao, G; Juncos, LA; Karakala, N; Nadim, MK; Parada, XV; Parikh, SM; Regner, KR; Sharma, P; Simonetto, DA; Velez, JCQ; Wadei, HM | 1 |
| Gupta, R; Kulkarni, AV; Kumar, K; Premkumar, M; Rao, PN; Ravikumar, ST; Reddy, DN; Sharma, M; Tevethia, H | 1 |
| Velez, JCQ | 1 |
| Allegretti, AS; Cárdenas, A; Francoz, C; Olson, JC; Subramanian, RM | 1 |
| Hidam, AK; Jain, P; Kadyan, S; Kumar, G; Maiwall, R; Pasupuleti, SSR; Rastogi, A; Sarin, SK; Singh, M | 1 |
| Ahn, J; Flamm, SL; Kamath, PS; Wong, F | 1 |
| Angeli, P; Basso, D; Brocca, A; Burra, P; Calvino, V; Cillo, U; Cosma, C; Gagliardi, R; Gambino, C; Incicco, S; Piano, S; Stenico, M; Tonon, M; Zaninotto, M; Zeni, N | 1 |
| Andrade, L; Castro, LUC; da Silva, C; Duarte-Neto, AN; Gomes, SA; Malbouisson, LS; Noronha, IL; Otsuki, DA; Sanches, TR; Santinho, MAR; Souza, FL | 1 |
| Kwo, P; Wong, F | 1 |
| Aschenbach, R; Franken, P; Platzer, S; Ripoll, C; Schuhmacher, U; Stallmach, A; Steighardt, J; Teichgräber, U; Wienke, A; Zipprich, A | 1 |
| Belcher, JM | 1 |
| Bajaj, JS; Duong, N; Kakadiya, P | 1 |
| Christaki, M; Despotis, G; Kalambokis, GN; Milionis, HJ; Tsiakas, I | 1 |
| Cheng, DY; Ou, WN; Wan, G; Xing, HC | 1 |
| Kulkarni, AV; Kumar, P; Rao, NP; Reddy, N | 1 |
| Anand, A; Deep, A; Saxena, R | 1 |
| Angeli, P; Boccagni, P; Burra, P; Calvino, V; Cillo, U; Gambino, C; Germani, G; Gringeri, E; Piano, S; Tonon, M; Vettore, E | 1 |
| Allegretti, AS; Jamil, K; Moore, K | 1 |
| De, A; Mehtani, R; Singh, V | 1 |
| Francoz, C; Sanchez, LO | 1 |
| Brown, K; Brown, RS; Burra, P; Flamm, SL; Kugelmas, M; Poordad, F; Saab, S; Samaniego-Picota, M; Wadei, HM | 1 |
| Gadano, A; Garcia-Olveira, L; Mauro, E | 1 |
| Francoz, C; Khemichian, S; Nadim, MK | 1 |
| Abouelenain, KM; Afifi, MH; Alsebaey, A; Kandil, MA; Mahmoud, MA; Rashed, HS; Yassen, KA | 1 |
| Golestaneh, L; Neugarten, J | 1 |
| Angeli, P; Piano, S; Tonon, M | 1 |
| Chen, G; Han, MF; Jiang, QQ; Kilonzo, SB; Ma, K; Ning, Q; Wan, XY; Wang, YL; Wu, WY; You, J | 1 |
| Arora, V; Jain, P; Jindal, A; Kumar, G; Maiwall, R; Muralikrishna Shasthry, S; Rajan, V; Sarin, SK | 1 |
| Angeli, P; Ginès, P; Kamath, PS; Nadim, MK; Solà, E; Wong, F | 1 |
| Agarwal, S; Gupta, S; Pandey, N; Singh, S; Verma, S | 1 |
| Satsangi, S | 1 |
| Anand, A | 1 |
| Moraes, RB; Nedel, WL; Pellegrini, JAS; Rech, TH; Ribeiro, RA | 1 |
| Borg, K; Lange, LB | 1 |
| Carol, M; Cereijo, U; dePrada, G; Fabrellas, N; Farrés, J; Ginès, P; Graupera, I; Huelin, P; Jiménez, W; Juanola, A; Mas, JM; Morales-Ruiz, M; Moreira, R; Napoleone, L; Pose, E; Solà, E; Solé, C; Torres, F | 1 |
| Arora, V; Jain, P; Jindal, A; Kumar, G; Maiwall, R; Rajan, V; Sarin, SK; Shasthry, SM | 1 |
| Gao, Y; Hou, B; Lin, S; Zhang, DD; Zhu, Y | 1 |
| Boyer, TD; Escalante, S; Jamil, K; Pappas, SC; Sanyal, AJ; Wong, F | 1 |
| Egerod Israelsen, M; Gluud, LL; Krag, A | 1 |
| Abdelaal, A; Aboul-Fetouh, F; Bahaa, M; Dabous, H; El Meteini, M; Fathy, M; Hasanin, A; Mahmoud, I; Mukhtar, A; Obayah, G | 1 |
| Janicko, M; Jarcuska, P; Senajova, G; Veseliny, E | 1 |
| Bhadoria, AS; Jindal, A; Maiwall, R; Sarin, SK | 1 |
| Bertino, G; Crisafulli, E; Demma, S; Koukias, N; Privitera, G; Purrello, F; Spadaro, L; Tsochatzis, EA | 1 |
| Kim, SM; Song, IH | 1 |
| Appuswamy, E; Kaliamoorthy, I; Lakshmi, S; Malleeshwaran, S; Rajakumar, A; Reddy, MS; Rela, M; Varghese, J | 1 |
| Lebrec, D; Moreau, R | 1 |
| Alahdab, Y; Ari, E; Arikan, H; Asicioglu, E; Atakan, A; Cakalagaoglu, F; Kahveci, A; Kedrah, AE; Kocak, H; Macunluoglu, B; Ozener, C; Tuglular, S; Yilmaz, Y | 1 |
| Aagaard, NK; Bendtsen, F; Grønbaek, H; Hansen, JB; Møller, S; Schmidt, L | 1 |
| Davenport, A | 1 |
| Decaux, G; Hannotier, P; Musch, W; Prospert, F; Soupart, A | 1 |
16 review(s) available for terlipressin and Acute Kidney Failure
| Article | Year |
|---|---|
Hepatorenal Syndrome Type 1: From Diagnosis Ascertainment to Goal-Oriented Pharmacologic Therapy.
Topics: Acute Kidney Injury; Goals; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Terlipressin | 2022 |
Respiratory events with terlipressin and albumin in hepatorenal syndrome: A review and clinical guidance.
Topics: Acute Kidney Injury; Albumins; Hepatorenal Syndrome; Humans; Lypressin; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2022 |
AGA Clinical Practice Update on the Evaluation and Management of Acute Kidney Injury in Patients With Cirrhosis: Expert Review.
Topics: Acute Kidney Injury; Albumins; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Creatinine; Diuretics; Humans; Liver Cirrhosis; Midodrine; Necrosis; Norepinephrine; Octreotide; Terlipressin | 2022 |
Hepatorenal Syndrome: Pathophysiology, Diagnosis, and Treatment.
Topics: Acute Kidney Injury; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Liver Transplantation; Terlipressin; Vasoconstrictor Agents | 2023 |
Current Pharmacologic Therapies for Hepatorenal Syndrome-Acute Kidney Injury.
Topics: Acute Kidney Injury; Albumins; Hepatorenal Syndrome; Humans; Multicenter Studies as Topic; Prospective Studies; Terlipressin; United States; Vasoconstrictor Agents | 2023 |
Global strategy for the diagnosis and management of acute kidney injury in patients with liver cirrhosis.
Topics: Acute Kidney Injury; Adult; Albumins; Biomarkers; Creatinine; Disease Progression; Early Diagnosis; Female; Fluid Therapy; Humans; Liver Cirrhosis, Alcoholic; Liver Transplantation; Prognosis; Terlipressin; Vasoconstrictor Agents | 2021 |
The Current Management of Hepatorenal Syndrome-Acute Kidney Injury in the United States and the Potential of Terlipressin.
Topics: Acute Kidney Injury; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Liver Transplantation; Terlipressin; United States; Vasoconstrictor Agents | 2021 |
Advances in management of hepatorenal syndrome.
Topics: Acute Kidney Injury; End Stage Liver Disease; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Terlipressin | 2021 |
Dual Organ Duel: The Hepatorenal Axis.
Topics: Acute Kidney Injury; Animals; Antihypertensive Agents; Antiviral Agents; Cytochrome P-450 Enzyme System; Hepatitis C; Hepatorenal Syndrome; Humans; Liver Diseases; Lypressin; Renal Insufficiency, Chronic; Terlipressin | 2017 |
Management of ascites and hepatorenal syndrome.
Topics: Acute Kidney Injury; Albumins; Ascites; Bacterial Translocation; Diet, Sodium-Restricted; Diuretics; Hemodynamics; Hepatorenal Syndrome; Humans; Hypertension, Portal; Hyponatremia; Liver Cirrhosis; Liver Transplantation; Lypressin; Paracentesis; Peritonitis; Portasystemic Shunt, Transjugular Intrahepatic; Splanchnic Circulation; Terlipressin; Vasoconstrictor Agents; Vasodilation | 2018 |
Hepatorenal syndrome.
Topics: Acute Kidney Injury; Bacterial Infections; Biomarkers; Creatinine; Fatty Acid-Binding Proteins; Hepatitis A Virus Cellular Receptor 1; Hepatorenal Syndrome; Humans; Inflammation; Interleukin-18; Lipocalin-2; Liver Cirrhosis; Risk Factors; Serum Albumin; Terlipressin; Vasoconstrictor Agents | 2018 |
Renal Outcomes of Vasopressin and Its Analogs in Distributive Shock: A Systematic Review and Meta-Analysis of Randomized Trials.
Topics: Acute Kidney Injury; Humans; Incidence; Randomized Controlled Trials as Topic; Renal Replacement Therapy; Shock; Terlipressin; Vasoconstrictor Agents; Vasopressins | 2019 |
Acute kidney injury and hepatorenal syndrome in cirrhosis.
Topics: Acute Kidney Injury; Albumins; Ascites; Disease Progression; Drug Therapy, Combination; Early Diagnosis; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Liver Transplantation; Lypressin; Portasystemic Shunt, Transjugular Intrahepatic; Terlipressin | 2015 |
Emerging hepatic syndromes: pathophysiology, diagnosis and treatment.
Topics: Acute Kidney Injury; Adrenal Insufficiency; Ascites; Creatinine; Evidence-Based Medicine; Hepatorenal Syndrome; Humans; Hypertension, Portal; Liver Cirrhosis; Liver Transplantation; Lypressin; Midodrine; Norepinephrine; Octreotide; Plasma Substitutes; Portasystemic Shunt, Transjugular Intrahepatic; Serum Albumin; Terlipressin; Vasodilator Agents; Vasopressins | 2016 |
[Acute Kidney Injury in Cirrhotic Patients with Portal Hypertension].
Topics: Acute Kidney Injury; Biomarkers; Creatinine; Humans; Hypertension, Portal; Kidney Transplantation; Liver Cirrhosis; Lypressin; Serum Albumin; Terlipressin | 2016 |
Acute kidney injury: new concepts. Hepatorenal syndrome: the role of vasopressors.
Topics: Acute Kidney Injury; Antihypertensive Agents; Humans; Hypertension, Portal; Lypressin; Terlipressin; Treatment Outcome; Vasopressins | 2008 |
6 trial(s) available for terlipressin and Acute Kidney Failure
| Article | Year |
|---|---|
Terlipressin and the Treatment of Hepatorenal Syndrome: How the CONFIRM Trial Moves the Story Forward.
Topics: Acute Kidney Injury; Female; Hepatorenal Syndrome; Humans; Lypressin; Male; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2022 |
Liver-HERO: hepatorenal syndrome-acute kidney injury (HRS-AKI) treatment with transjugular intrahepatic portosystemic shunt in patients with cirrhosis-a randomized controlled trial.
Topics: Acute Kidney Injury; Albumins; Ascites; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Portasystemic Shunt, Transjugular Intrahepatic; Prospective Studies; Quality of Life; Terlipressin | 2023 |
Impact of terlipressin infusion during and after live donor liver transplantation on incidence of acute kidney injury and neutrophil gelatinase-associated lipocalin serum levels: A randomized controlled trial.
Topics: Acute Kidney Injury; Adult; Aged; Double-Blind Method; Drug Administration Schedule; Female; Humans; Incidence; Infusions, Intravenous; Lipocalin-2; Liver Transplantation; Living Donors; Logistic Models; Lypressin; Male; Middle Aged; Postoperative Complications; Prospective Studies; Terlipressin; Vasoconstrictor Agents | 2017 |
Terlipressin Is Superior to Noradrenaline in the Management of Acute Kidney Injury in Acute on Chronic Liver Failure.
Topics: Acute Kidney Injury; Acute-On-Chronic Liver Failure; Adult; Female; Humans; Male; Middle Aged; Norepinephrine; Prospective Studies; Terlipressin; Vasoconstrictor Agents | 2020 |
Reduction in acute kidney injury stage predicts survival in patients with type-1 hepatorenal syndrome.
Topics: Acute Kidney Injury; Aged; Double-Blind Method; Female; Hepatorenal Syndrome; Humans; Male; Middle Aged; Prognosis; Survival Rate; Terlipressin; Vasoconstrictor Agents | 2020 |
Double-blind randomized controlled trial of the routine perioperative use of terlipressin in adult living donor liver transplantation.
Topics: Acute Kidney Injury; Adult; Ascites; Bradycardia; Double-Blind Method; Female; Humans; Incidence; Infusions, Intravenous; Kidney Failure, Chronic; Length of Stay; Liver Function Tests; Liver Transplantation; Living Donors; Lypressin; Male; Middle Aged; Perioperative Period; Portal Pressure; Postoperative Complications; Severity of Illness Index; Terlipressin; Vasoconstrictor Agents | 2017 |
28 other study(ies) available for terlipressin and Acute Kidney Failure
| Article | Year |
|---|---|
Safety and efficacy of terlipressin in acute-on-chronic liver failure with hepatorenal syndrome-acute kidney injury (HRS-AKI): a prospective cohort study.
Topics: Acute Kidney Injury; Acute-On-Chronic Liver Failure; Adult; Hepatorenal Syndrome; Humans; Lypressin; Prospective Studies; Terlipressin; Vasoconstrictor Agents | 2022 |
Natural history, spectrum and outcome of stage 3 AKI in patients with acute-on-chronic liver failure.
Topics: Acute Kidney Injury; Acute-On-Chronic Liver Failure; Bilirubin; Humans; Risk Factors; Terlipressin | 2022 |
Diagnostic and prognostic performance of urinary neutrophil gelatinase-associated lipocalin in patients with cirrhosis and acute kidney injury.
Topics: Acute Kidney Injury; Acute-Phase Proteins; Biomarkers; End Stage Liver Disease; Humans; Lipocalin-2; Lipocalins; Liver Cirrhosis; Prognosis; Proto-Oncogene Proteins; Severity of Illness Index; Terlipressin | 2023 |
Terlipressin combined with conservative fluid management attenuates hemorrhagic shock-induced acute kidney injury in rats.
Topics: Acute Kidney Injury; Animals; Arginine Vasopressin; Rats; Rats, Wistar; Receptors, Vasopressin; Ringer's Lactate; Shock, Hemorrhagic; Terlipressin | 2022 |
Practical Management of HRS-AKI in the Era of Terlipressin: What the Gastroenterologist Needs to Know.
Topics: Acute Kidney Injury; Gastroenterologists; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2023 |
Efficacy of treatment with terlipressin plus albumin in hepatorenal syndrome diagnosed with the new acute kidney injury versus the conventional criteria.
Topics: Acute Kidney Injury; Albumins; Drug Therapy, Combination; Hepatorenal Syndrome; Humans; Kaplan-Meier Estimate; Practice Guidelines as Topic; Retrospective Studies; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2019 |
[Clinical curative effect observation of therapy of terlipressin combined with albumin in acute kidney injury with liver cirrhosis].
Topics: Acute Kidney Injury; Albumins; Humans; Liver Cirrhosis; Terlipressin | 2019 |
Terlipressin-induced ischaemic skin necrosis.
Topics: Acute Kidney Injury; Acute-On-Chronic Liver Failure; Diagnosis, Differential; Humans; Ischemia; Male; Middle Aged; Necrosis; Skin Diseases; Terlipressin | 2020 |
Use of terlipressin in critically ill children with liver disease.
Topics: Acute Kidney Injury; Adolescent; Ascites; Child; Creatinine; Critical Illness; Cyanosis; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Hepatorenal Syndrome; Humans; Intensive Care Units, Pediatric; Ischemia; Liver Diseases; Male; Terlipressin; Vasoconstrictor Agents | 2020 |
Response to Terlipressin and Albumin Is Associated With Improved Liver Transplant Outcomes in Patients With Hepatorenal Syndrome.
Topics: Acute Kidney Injury; Albumins; Female; Hepatorenal Syndrome; Humans; Liver Transplantation; Male; Middle Aged; Renal Replacement Therapy; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2021 |
Letter: HRS-AKI-a frequent misdiagnosis in the real world setting? Authors' reply.
Topics: Acute Kidney Injury; Diagnostic Errors; Hepatorenal Syndrome; Humans; Terlipressin | 2020 |
Letter: HRS-AKI - a frequent misdiagnosis in the real-world setting?
Topics: Acute Kidney Injury; Diagnostic Errors; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Terlipressin | 2020 |
End-stage liver disease: Management of hepatorenal syndrome.
Topics: Acute Kidney Injury; End Stage Liver Disease; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Terlipressin; Vasoconstrictor Agents | 2021 |
Acute kidney injury in acute-on-chronic liver failure is different from in decompensated cirrhosis.
Topics: Acute Kidney Injury; Acute-On-Chronic Liver Failure; Adult; Biomarkers; Disease Progression; Female; Hepatitis B virus; Humans; Kidney Tubules; Liver Cirrhosis; Lypressin; Male; Middle Aged; Prospective Studies; Risk Factors; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2018 |
Letter To Editor: Terlipressin is Superior to Noradrenaline in the Management of Acute Kidney Injury in Acute On Chronic Liver Failure.
Topics: Acute Kidney Injury; Acute-On-Chronic Liver Failure; Humans; Lypressin; Norepinephrine; Terlipressin | 2018 |
Noradrenaline for Hepatorenal Syndrome in Patients With Acute on Chronic Liver Failure: Hope Remains!
Topics: Acute Kidney Injury; Acute-On-Chronic Liver Failure; Hepatorenal Syndrome; Humans; Norepinephrine; Terlipressin | 2018 |
Is Terlipressin Superior to Noradrenaline in the Treatment of Acute Kidney Injury in Acute-on-Chronic Liver Failure?
Topics: Acute Kidney Injury; Acute-On-Chronic Liver Failure; Humans; Lypressin; Norepinephrine; Terlipressin | 2019 |
[Severe reversible penile ischaemia after terlipressin treatment of hepatorenal syndrome].
Topics: Acute Kidney Injury; Aged; Hepatorenal Syndrome; Humans; Ischemia; Liver Cirrhosis, Alcoholic; Lypressin; Male; Penis; Terlipressin; Vasoconstrictor Agents | 2018 |
Characterization of inflammatory response in hepatorenal syndrome: Relationship with kidney outcome and survival.
Topics: Acute Kidney Injury; Acute-On-Chronic Liver Failure; Aged; Albumins; Biomarkers; Cytokines; Female; Hepatorenal Syndrome; Humans; Inflammation; Kidney; Liver; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Prospective Studies; Severity of Illness Index; Spain; Survival Analysis; Terlipressin; Vasoconstrictor Agents | 2019 |
Reply.
Topics: Acute Kidney Injury; Acute-On-Chronic Liver Failure; Humans; Norepinephrine; Terlipressin | 2019 |
Letter to Editor: The Synergistic Effect of Albumin on Terlipressin in Acute-on-Chronic Liver Failure With Acute Kidney Injury.
Topics: Acute Kidney Injury; Acute-On-Chronic Liver Failure; Albumins; Humans; Lypressin; Norepinephrine; Terlipressin | 2019 |
Intraoperative terlipressin therapy reduces the incidence of postoperative acute kidney injury after living donor liver transplantation.
Topics: Acute Kidney Injury; Adult; Aged; Case-Control Studies; Female; Humans; Incidence; Intraoperative Care; Liver Transplantation; Living Donors; Lypressin; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Terlipressin; Treatment Outcome | 2015 |
Predictors of hepatorenal syndrome in alcoholic liver cirrhosis.
Topics: Acute Kidney Injury; Albumins; Analysis of Variance; Antihypertensive Agents; Female; Follow-Up Studies; Hepatorenal Syndrome; Humans; Liver Cirrhosis, Alcoholic; Lypressin; Male; Middle Aged; Risk Factors; Terlipressin | 2015 |
Evaluation of acute kidney injury and its response to terlipressin in patients with acute-on-chronic liver failure.
Topics: Acute Kidney Injury; Acute-On-Chronic Liver Failure; Adult; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Humans; India; Lypressin; Male; Middle Aged; Peritonitis; Retrospective Studies; Severity of Illness Index; Survival Analysis; Terlipressin; Vasoconstrictor Agents | 2016 |
Protective effect of the vasopressin agonist terlipressin in a rat model of contrast-induced nephropathy.
Topics: Acute Kidney Injury; Animals; Contrast Media; Disease Models, Animal; Kidney Function Tests; Lypressin; Rats; Rats, Inbred BB; Terlipressin; Vasoconstrictor Agents; Vasopressins | 2011 |
Treatment of the hepatorenal syndrome and hyponatremia in cirrhosis - part II.
Topics: Acute Kidney Injury; Clinical Protocols; Contraindications; Diuretics; Evidence-Based Medicine; Fluid Therapy; Hepatorenal Syndrome; Humans; Hyponatremia; Liver Cirrhosis; Lypressin; Renal Insufficiency, Chronic; Terlipressin; Vasoconstrictor Agents; Water-Electrolyte Imbalance | 2012 |
AKI in a patient with cirrhosis and ascites.
Topics: Acute Kidney Injury; Adult; Ascites; Creatinine; Female; Fluid Therapy; Glomerular Filtration Rate; Humans; Hypotension; Hypovolemia; Liver Cirrhosis; Lypressin; Oliguria; Paracentesis; Terlipressin; Vasoconstrictor Agents | 2012 |
Restoration of the uricosuric effect of probenecid after triglycylvasopressine administration in a gouty patient.
Topics: Absorption; Acute Kidney Injury; Adult; Anti-Inflammatory Agents; Benzbromarone; Fludrocortisone; Gout; Humans; Kidney Tubules; Lypressin; Male; Probenecid; Pyrazinamide; Receptors, Vasopressin; Renal Agents; Terlipressin; Uric Acid; Uricosuric Agents | 1998 |